Actualités sur Health

Earth Council Geneva

Promoting Environmental Health Interventions: International Medical Corps and Earth Council Geneva Launch Strategic Partnership

Los Angeles, CA/Geneva, Switzerland (ots) - In an effort to find sustainable solutions to global environmental health problems International Medical Corps and Earth Council Geneva have launched a strategic partnership that will benefit communities impacted by the severe scarcity of vital resources. The new ...

Solianis Monitoring AG

Scientific Recognition for Solianis based on Successful Tests

Zurich, Swizerland (ots) - Recently, Solianis successfully finalized a series of tests during which patients with diabetes have worn its multisensor device for non-invasive glucose monitoring at home and at work in the office. The results of these real-life tests as well as earlier tests in a more controlled environment have encouraged Solianis to set up the final device and prepare the market introduction for 2010. ...

Ferring International SA

European Commisssion grants Ferring Pharmaceuticals approval of FIRMAGON® (degarelix) for treatment of prostate cancer

New gonadotrophin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone Saint-Prex (ots) - Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON® (degarelix), a new GnRH receptor antagonist ...

DNArtistic and Inneova Corporation Limit

DNA Jewel to Finance Anti-Aging Services & Cancer Research

Geneva (ots) - Swiss-based www.dnartistic.com 's first piece of DNA luxury jewellery will be sold at 1 million CHF and some of the proceeds will be used to finance the anti-aging services and life extension research of sister company www.inneova.com. Dr. Ivan de Weber, a young Swiss scientist specialized in molecular genetics of aging and co-founder of both Inneova™ and DNArtistic has brought together a group of ...

Solianis Monitoring AG

Non-invasive glucose monitoring - Solianis Monitoring AG Breakthrough home use study finalized - Board of Directors reinforce

Zurich (ots) - Solianis has just finalized a test series in which patients with diabetes have worn the first configuration of the multisensor system for non-invasive Continuous Glucose Monitoring at home and at work. Results show that the system tracks glucose in these settings and that it is sensitive to hyper- ...

Gene Signal International SA

Gene Signal enters Phase III clinical tests for the prevention of Corneal Graft Rejection

Lausanne (ots) - - Gene Signal International, a biotech company registered in Switzerland, will move its headquarter to the EPFL, in Lausanne, - Gene Signal is addressing various issues related to neovascularisation, - Gene Signal is working on a portfolio of ophthalmologic indications, with one now in Phase III trials - Gene Signal ...

Sonnenhof Swiss Health Ltd.

Sonnenhof Swiss Health is taking "Swissness" to hospitals in India

Berne (ots) - Swiss hospital standards are in demand abroad. In collaboration with an Indian company, Sonnenhof Swiss Health Ltd (SSH) introduces a new service offering for leading Indian hospitals with the aim of their attaining Swiss quality assurance standards. The cooperation of Hexel and SSH is based on a combination of strengths. SSH - an associated company of the Sonnenhof hospitals in Bern - can draw on ...

Solianis Monitoring AG

Convincing results of Solianis' multisensor system in home-use trial

Zurich, (ots) - Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work environment. 12 patients have completed a 10-day trial aimed at assessing system reliability. Results indicate that the system tracks glucose in home-use settings and is sensitive to hypoglycemic glucose ...

Me-First.ch

The computer mouse becomes more comfortable

Axxonis Pharma AG

Axxonis Pharma AG, has identified and patented several new chemical entities as neuroprotective agents

Berlin (ots) - The new compounds will provide a "full time" protection of neurons against aging and degeneration. Continuous administration technologies, which are one of the core competencies of Axxonis Pharma AG, will additionally enable the concept of 24 hours protection. This is a completely new and innovative approach in radical scavenging therapy and in ...

DSM Nutritional Products AG

DSM Nutritional Products: Fending off dementia: Beta-Carotene shown to improve memory

Kaiseraugst (ots) - A new scientific study has shown that consuming beta-carotene over a long period of time may help to preserve mental fitness by improving how the brain, and more importantly the memory, works. While it has long been acknowledged that eating beta-carotene-rich foods or taking supplements of this antioxidant can help to protect the skin from ...

Helsinn Healthcare SA

Helsinn Healthcare SA: Palonosetron - The long-lasting antiemetic action finds its basis

New data on the mechanism of action of the second generation 5-HT3 antagonist palonosetron presented today at the 33rd ESMO Congress in Stockholm, Sweden Stockholm, Sweden (ots) - New data presented today at the 33rd ESMO (European Society of Medical Oncology) Congress in Stockholm may contribute to explain the reason why palonosetron, a second generation 5-HT3 ...

Novozymes Switzerland AG

Cut your ingredient costs with Novozymes' Lipopan® Xtra and Lipopan® F

Dittingen, Switzerland (ots) - Throughout recent times, consumer tastes have been honed to enjoy a wide variety of quality bread products. But manufacturers are posed with an escalating dilemma - how to counteract the ever-rising ingredient prices with cost-effective alternatives that ensure bread improvement. With bread remaining an important element in daily diets ...

European Society for Medical Oncology (ESMO)

33rd ESMO Congress in Stockholm, 12-16 September 2008

Lugano (ots) - The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines. The Congress Centre will be the venue for interdisciplinary interaction, a teaching ground, and a place to discuss critical issues for European oncology such as cancer research in Europe, the ...

Solianis Monitoring AG

Solianis' novel multisensor technology monitors hydration changes in skin - two patents submitted opening new horizons for cosmetic manufacturers and customers

Zurich (ots) - Solianis' new patents cover the basic technology to monitor changes in the hydration of skin at different depths and to evaluate the impact of cosmetic products: "Device and method for determining at least one characterizing parameter of multilayer body tissue" and "Method and device for ...

Helsinn Healthcare SA

Successful Inspection of Helsinn Birex Pharmaceuticals Dublin, Ireland by the US Food and Drug Administration

Dublin, Ireland (ots) - Helsinn is pleased to announce that Helsinn Birex Pharmaceuticals, its drug facility in Dublin Ireland, has undergone a successful inspection by the US Food and Drug Administration (FDA) without any Form 483 observations. The FDA visit, which lasted 5 days, was a pre-approval inspection ...

Helsinn Healthcare SA

Helsinn Healthcare SA announces the launch of ALOXI® (palonosetron hcl) injection for the prevention of postoperative nausea and vomiting in the USA

Lugano (ots) - Helsinn's Top Management and its U.S. partner Eisai Inc. today announced the availability in the USA of ALOXI® (palonosetron hydrochloride) injection 0.075 mg for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. The introduction of ALOXI® for PONV ...

Solianis Monitoring AG

Solianis' Non-Invasive Glucose Monitor Tracks Blood Glucose in Outpatient Study

Zurich (ots) - Solianis is conducting a study in which patients with diabetes are testing a preliminary functional model of the future device for non-invasive glucose monitoring. First results confirm the expected applicability of the multisensor platform in everyday life. Solianis' unique multisensor platform offers an easy and reliable monitoring of changes ...

DSM Nutritional Products AG

Good news for the summer: Beta-Carotene helps to protect against sunburn

Kaiseraugst (ots) - If "an apple a day keeps the doctor away", a carrot a day might help to keep the sun burn away. That is the conclusion of a recently published analysis by Professors Wolfgang Köpcke and Jean Krutmann, of Münster University Hospital and the Institut für Umweltmedizinische Forschung in Düsseldorf, Germany, respectively. In a paper ...

DSM Nutritional Products AG

Oily fish are good for you, but there is an alternative route to Omega-3

Basel (ots) - Herring sandwich? Mackerel soufflé? Salmon fondue? If these items don't form part of your diet, you might be missing out on something. That something is long-chain Omega-3 polyunsaturated fatty acids, a substance vital to good health which is found primarily in oily fish. Consumed regularly, Omega-3 can help in the battle against a variety of ...

Ergonex Pharma GmbH

Ergonex Pharma: Terguride receives FDA orphan drug designation for the treatment of pulmonary arterial hypertension

Appenzell (ots) - Ergonex Pharma today announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe. "The ...

Helsinn Healthcare SA

FDA approves ALOXI® (Palonosetron HCl) injection for prevention of postoperative nausea and vomiting

Lugano (ots) - Helsinn Healthcare SA, a Swiss pharmaceutical group, together with its partner EISAI Corporation of North America and EISAI's U.S. subsidiary, MGI Pharma, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi® (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for ...

Solianis Monitoring AG

Continuous non-invasive glucose monitoring - Solianis Monitoring AG: Multi-sensor technology drives clinical progress

Zürich (ots) - Solianis sees its Multi-Sensor Technology as a promising approach to continuous non-invasive glucose monitoring. Professor Marc Donath, member of the Solianis Scientific Advisory Board and Professor for endocrinology and diabetology at the University Hospital in Zürich, Switzerland, has ...

Juvena of Switzerland

Juvena of Switzerland: Live Chat with Prof. Dr. Sven Gohla. Topic: Skincare

Volketswil-Zurich (ots) - Juvena of Switzerland, a Swiss cosmetics company established in 1954, launched its Juvedical renewing serum in 2004, thus attracting an ever-growing fan base. Consumers love the product, and express their enthusiasm in letters and emails, which the company receives daily. Physicians and scientists-as well as 15 international awards-confirm ...